Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03610724
Title Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients (BIANCA)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

gray zone lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

Burkitt lymphoma

primary mediastinal B-cell lymphoma

Therapies

Tisagenlecleucel

Age Groups: adult | child
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | AUT


No variant requirements are available.